Alliancebernstein L.P. Instil Bio, Inc. Transaction History

Alliancebernstein L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.48 - $5.33 $60,230 - $668,808	-125,480 Reduced 61.64%	78,100 $49,000
Q3 2022 Nov 15, 2022	BUY	$4.65 - $7.37 $39,990 - $63,382	8,600 Added 4.41%	203,580 $985,000
Q2 2022 Aug 15, 2022	SELL	$4.21 - $11.15 $12.5 Million - $33 Million	-2,959,290 Reduced 93.82%	194,980 $901,000
Q1 2022 May 13, 2022	BUY	$8.48 - $18.1 $818,133 - $1.75 Million	96,478 Added 3.16%	3,154,270 $33.9 Million
Q4 2021 Feb 14, 2022	BUY	$15.37 - $22.5 $3.44 Million - $5.04 Million	224,067 Added 7.91%	3,057,792 $52.3 Million
Q3 2021 Nov 10, 2021	SELL	$15.05 - $23.28 $245,676 - $380,022	-16,324 Reduced 0.57%	2,833,725 $50.7 Million
Q2 2021 Jul 30, 2021	BUY	$15.31 - $24.63 $12.7 Million - $20.4 Million	828,321 Added 40.97%	2,850,049 $55.1 Million
Q1 2021 May 06, 2021	BUY	$24.23 - $27.06 $49 Million - $54.7 Million	2,021,728 New	2,021,728 $50.7 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.